Australian COVID-19 immunization:produces antibody response in early tests

Australian COVID-19 immunization:produces antibody response in early tests

Overview

  • Post By : Kumar Jeetendra

  • Source: Reuters

  • Date: 13 Nov,2020

Early testing of an expected COVID-19 vaccine developed by an Australian university and CSL has revealed it to be secure and produce an antibody response, Minister for Health Greg Hunt said on Friday.

Pharmaceutical companies are rushing to create effective treatments for the illness amid a spike in COVID-19 cases that has killed over a million people and battered the world’s market.

Several candidates such as ones produced Pfizer and AstraZeneca are expected to imminently announce the results from past stage testing.

Pfizer stated earlier this week that its experimental COVID-19 vaccine had been greater than 90 percent effective based on initial trial results.

While marginally behind other candidates, the vaccine candidate developed by the University of Queensland and CSL will now start the last stage of testing, Hunt said.

“The vaccine is proving to be more safe through phase I clinical trials and it is proving to produce a positive antibody response,” Hunt told colleagues in Queensland.

“It’s doing its job. That is especially so in the elderly, and that is an especially important outcome, given that the global vulnerability to older around the world from COVID-19.”

If it pass these trials, Hunt said it may be prepared for distribution from the third quarter of 2021.

Australia has agreed to buy 51 million does of the University of Queensland developed candidate. Australia will also buy the AstraZeneca vaccine too should it pass last phase testing.

About Author